UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $270 to $310.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
The AI economy, Apple's iPhone Duo issues, and Meta partners with Nvidia
Yahoo51 Minutes Ago
Can Apple charge $38.99 for new Siri AI?
Yahoo59 Minutes Ago
Pfizer (PFE) Scores Phase 3 Cancer Win As FDA Broadens Another Oncology Approval
Yahoo1 Hour Ago
The Sherwin-Williams Company Q3 2026 Earnings Call Summary
Yahoo1 Hour Ago
Which Real Estate ETF Is the Better Buy: State Street’s XLRE or Northern Trust’s Global GQRE?
Yahoo2 Hours Ago
Alpaca · SIPUpdated 14:10 NY15 Minutes DelayedMay Be Out Of Date
